Clinical Trials · NCT03497702
Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- National Cancer Center, Korea
- Enrollment
- 114
- Start date
- May 2017
- Locations
- 1 site, South Korea
- Primary endpoint
- pathologic complete remission (pCR)